Cargando…
Systemic adverse events after screening of retinopathy of prematurity with mydriatic
PURPOSE: To evaluate systemic adverse events after screening for retinopathy of prematurity (ROP) performed with mydriatic. METHODS: This was a retrospective case series study. Medical records of consecutive patients who underwent screening for ROP with 0.5% phenylephrine and 0.5% tropicamide eyedro...
Autores principales: | Obata, Shumpei, Imamura, Taku, Kakinoki, Masashi, Yanagi, Takahide, Maruo, Yoshihiro, Ohji, Masahito |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428556/ https://www.ncbi.nlm.nih.gov/pubmed/34499693 http://dx.doi.org/10.1371/journal.pone.0256878 |
Ejemplares similares
-
Short-Term Changes in Intraocular Pressure After Intravitreal Injection of Bevacizumab for the Treatment of Retinopathy of Prematurity
por: Obata, Shumpei, et al.
Publicado: (2019) -
Effect of intravitreal bevacizumab for retinopathy of prematurity on weight gain
por: Obata, Shumpei, et al.
Publicado: (2021) -
Changes in fetal growth restriction and retinopathy of prematurity during the coronavirus disease 2019 pandemic: A cross-sectional study
por: Obata, Shumpei, et al.
Publicado: (2022) -
Systematic review of mydriatics used for screening of retinopathy in premature infants
por: Kremer, Lisa Jean, et al.
Publicado: (2019) -
Comparison of Surgical Outcomes Between Two Types of Lamellar Macular Holes
por: Obata, Shumpei, et al.
Publicado: (2019)